Compliance can be greatly improved by concentrating on the basic elements of CAPA investigations, advises Kate Rice, global quality systems manager, Nelson Laboratories, and Susan J. Schniepp, distinguished fellow, Regulatory Compliance Associates.
Kate Rice
Advertisement
Kate Rice is global quality systems manager, Nelson Laboratories.
Articles by Kate Rice
Advertisement
Latest Updated Articles
Focusing on Effectiveness for CAPAsPublished: April 1st 2024 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Regulatory Challenges for Global Manufacturing of Vaccines
2
AI-Driven Organ-on-Chip Platforms Are Changing the Game in Bio/Pharma R&D
3
EU Biopharma Strategy: Scaling Up to Tackle Funding Gaps and Drive Innovation
4
Q&A: From Lab to Clinic—Leveraging Organ-on-Chip and AI to Improve Therapeutic Development
5
